FIELD: medicine.
SUBSTANCE: invention describes a method of determining the efficacy of haemostimulators in cytostatic myelosuppression involving the blood cell analysis with examining the content and differentiation of stem hemopoietic cells and committed progenitor; if observing the differentiation of the stem hemopoietic cells in granulocytic macrophage and granulocytic progenitors mainly, the preparations are considered to be haemostimulators stimulating granulomonocytopoiesis, and the differentiation in the granulocytic cells only enables to consider the haemostimulators of granulocytic hematopoietic lineage.
EFFECT: method enables choosing the most effective drugs for medical products for haematological correction considering a pathogenesis, and avoiding the developing complications.
1 ex, 12 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR SIMULATING CHRONIC CYTOSTATIC MYELOSUPPRESSION | 2012 |
|
RU2488890C1 |
METHOD OF STIMULATION IN VITRO PLURIPOTENT HEMOPOETIC STEM CELLS | 2010 |
|
RU2439147C1 |
METHOD OF GRANULOCYTOPOIESIS DEPRESSION CORRECTION IN CYTOSTATIC ACTION | 2008 |
|
RU2366422C1 |
METHOD OF MYELOPOIESIS STIMULATION | 2008 |
|
RU2366452C1 |
AGENT POSSESSING ANTI-INFLAMMATORY AND ANTIFIBROTIC ACTION IN PULMONARY TISSUE, AND CYTOSTATIC ACTION | 2012 |
|
RU2479312C1 |
AGENT INTENSIFYING ACTION OF BIOLOGICALLY ACTIVE SUBSTANCES AND DRUGS | 2009 |
|
RU2421239C1 |
MEANS OF HEMOSTIMULATING ACTION | 2016 |
|
RU2649817C2 |
HEMOSTIMULATING AGENT | 2017 |
|
RU2647833C1 |
MEDICATION OF STIMULATION OF STEM CELL PRODUCTION IN BONE MARROW | 2007 |
|
RU2410116C2 |
METHOD OF INTENSIFICATION OF STEM CELLS MOBILISATION | 2006 |
|
RU2330674C1 |
Authors
Dates
2011-06-20—Published
2009-06-30—Filed